Somatic evolution as an aging timer and driver
PrimaryAgeCurve's Cell Tree Rings theory is that somatic mutations are not only correlated biomarkers of aging but also mechanistically connected to aging because they are both markers and drivers of the aging process. Single-cell somatic variants can be used to infer cell lineage trees, and the geometry of those trees records the individual's somatic evolutionary history over the lifespan. The testable prediction is that metrics derived from cell lineage tree structure should correlate with chronological age and with clinical biomarkers of aging or health status. The reported Cell Tree Age model supports this prediction by correlating with chronological age and by predicting some clinical biomarkers, such as glucose, albumin, and leukocyte count, better than chronological age alone.
Popperian evaluation
The premise is credible but still only partly nailed down. Somatic mutations accumulate with age, can mark cell lineage history, and can contribute to dysfunction through clonal expansion, cancer risk, and altered tissue composition. The stronger claim is that lineage-tree geometry tracks biological aging status, not just age and blood-cell sampling history. That is plausible, but the evidence given does not yet separate biology cleanly from technical noise, cell-type mix, immune history, and sequencing coverage.
Supporting evidence: Somatic mutations are described as both markers and mechanistic contributors to aging.; Single-cell somatic variants can be detected from scRNA-seq and used to infer lineage trees.; The reported Cell Tree Age model used 31 phylogenetic tree metrics and correlated with chronological age at Pearson r = 0.81 in the main dataset.
Counter evidence: The theory depends on the assumption that inferred tree metrics reflect meaningful somatic evolution rather than variant-calling artifacts, sampling effects, or scRNA-seq coverage bias.; The evidence is mainly from peripheral blood mononuclear cells, so tissue-general aging claims remain under-tested.; Correlation with age does not by itself prove that the tree structure drives aging.
The theory explains why a lineage-tree clock might work: mutations record cell divisions and clonal history, so the tree should carry age-related information. The reported correlations fit that story. The weaker part is the driver claim. Clinical biomarkers such as glucose, albumin, and leukocyte count may correlate with cell-tree age because both track inflammation, immune composition, disease burden, or sample composition. The theory has real signal, but alternative explanations are still alive and annoying in the way good controls are supposed to be annoying.
Supporting evidence: Cell Tree Age predicted chronological age with Pearson r = 0.81 and median absolute error of about 4 years in the reported dataset.; A public scRNA-seq dataset test yielded Pearson r = 0.85 with chronological age.; Cell tree age predicted some clinical biomarkers better than chronological age alone, including glucose, albumin, and leukocyte count.
Counter evidence: The current evidence supports an aging timer more directly than it supports somatic evolution as a causal aging driver.; Blood-cell lineage structure can reflect immune history, clonal hematopoiesis, infection exposure, and cell-type composition, which could mimic biological aging signal.; The provided evidence does not show that changing somatic evolutionary structure changes aging phenotypes.
This theory makes clear testable claims. If tree metrics do not correlate with age in independent cohorts, fail across tissues, lose biomarker signal after cell-type and technical controls, or fail to predict longitudinal health change, the timer claim takes a direct hit. The causal driver claim is harder but still testable: interventions or natural experiments that alter clonal structure should shift aging phenotypes in the predicted direction. A theory that can be embarrassed by a well-designed dataset is doing real scientific work.
Supporting evidence: The stated prediction is that lineage-tree metrics should correlate with chronological age.; A second stated prediction is that lineage-tree metrics should correlate with clinical biomarkers of aging or health status.; The model gives quantitative outputs, including Pearson correlations and age prediction error, which can be compared across cohorts and protocols.
Counter evidence: The theory could become too flexible if any age-associated tree feature is treated as support after model selection.; The causal driver component needs stronger prospective or interventional tests than the currently reported correlations.; Technical artifacts in variant detection could make failed replication hard to interpret unless protocols and negative controls are specified in advance.
Reasoning tree
Public endorsements
Csordas publicly backs this theory. He is identified as AgeCurve's founder, he coauthored the 2024 Cell Tree Rings paper that frames somatic evolution as a human aging timer, and he is listed as an inventor on the related Cell Tree Rings patent filed by AgeCurve. That is direct public endorsement, not a passing mention.
Evidence publication IDs: 76e33f30-776e-41fe-9e94-35626b3882c5, 6226af2e-ea9b-4e4f-ab03-04a47792f20a